Company Filing History:
1 out of 12 
1 out of 3,539 
Years Active: 2006
Title: The Innovative Contributions of Robert C. Moen
Introduction
Robert C. Moen is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of medicine, particularly in the area of therapeutic treatments for newborns. His innovative approach has led to advancements in the use of engineered cells for medical applications.
Latest Patents
Robert C. Moen holds a patent for a method of providing a therapeutic effect in a human patient. This method involves administering CD34+ cells obtained from cord blood, which have been engineered with at least one nucleic acid sequence encoding a therapeutic agent. The engineering of these cells is achieved by transducing them with a retroviral vector that includes the nucleic acid sequence. This groundbreaking method has been applied in treating newborn infants suffering from ADA deficiency.
Career Highlights
Throughout his career, Robert C. Moen has worked with prestigious organizations such as Children's Hospital of Los Angeles and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to significant advancements in medical research and treatment methodologies.
Collaborations
Robert C. Moen has collaborated with esteemed colleagues, including Donald B. Kohn and R. Michael Blaese. These partnerships have further enhanced his research and the impact of his inventions in the medical field.
Conclusion
Robert C. Moen's innovative work in the field of therapeutic treatments exemplifies the importance of engineering in medicine. His contributions have the potential to change lives, particularly for vulnerable populations such as newborns.